Logo image of CMCM

CHEETAH MOBILE INC - ADR (CMCM) Stock Fundamental Analysis

NYSE:CMCM - New York Stock Exchange, Inc. - US1630752038 - ADR - Currency: USD

5.75  -0.17 (-2.87%)

After market: 6.08 +0.33 (+5.74%)

Fundamental Rating

2

Taking everything into account, CMCM scores 2 out of 10 in our fundamental rating. CMCM was compared to 284 industry peers in the Software industry. Both the profitability and financial health of CMCM have multiple concerns. CMCM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CMCM was profitable.
CMCM had negative earnings in 4 of the past 5 years.
CMCM had negative operating cash flow in 4 of the past 5 years.
CMCM Yearly Net Income VS EBIT VS OCF VS FCFCMCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

CMCM has a worse Return On Assets (-10.70%) than 61.23% of its industry peers.
The Return On Equity of CMCM (-24.55%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.7%
ROE -24.55%
ROIC N/A
ROA(3y)-9.32%
ROA(5y)-5.13%
ROE(3y)-17.51%
ROE(5y)-9.73%
ROIC(3y)N/A
ROIC(5y)N/A
CMCM Yearly ROA, ROE, ROICCMCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

1.3 Margins

The Gross Margin of CMCM (65.36%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CMCM has remained more or less at the same level.
CMCM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-1.1%
CMCM Yearly Profit, Operating, Gross MarginsCMCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

2

2. Health

2.1 Basic Checks

CMCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CMCM has been increased compared to 1 year ago.
Compared to 5 years ago, CMCM has more shares outstanding
Compared to 1 year ago, CMCM has a worse debt to assets ratio.
CMCM Yearly Shares OutstandingCMCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CMCM Yearly Total Debt VS Total AssetsCMCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that CMCM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.24, CMCM is not doing good in the industry: 71.01% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.00 indicates that CMCM is not too dependend on debt financing.
The Debt to Equity ratio of CMCM (0.00) is better than 65.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC12.47%
CMCM Yearly LT Debt VS Equity VS FCFCMCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

2.3 Liquidity

CMCM has a Current Ratio of 1.27. This is a normal value and indicates that CMCM is financially healthy and should not expect problems in meeting its short term obligations.
CMCM's Current ratio of 1.27 is on the low side compared to the rest of the industry. CMCM is outperformed by 61.59% of its industry peers.
A Quick Ratio of 1.27 indicates that CMCM should not have too much problems paying its short term obligations.
The Quick ratio of CMCM (1.27) is worse than 60.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CMCM Yearly Current Assets VS Current LiabilitesCMCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

CMCM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.77%.
Measured over the past years, CMCM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
Looking at the last year, CMCM shows a very negative growth in Revenue. The Revenue has decreased by -27.98% in the last year.
The Revenue has been growing by 14.06% on average over the past years. This is quite good.
EPS 1Y (TTM)-72.77%
EPS 3Y14.63%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-27.98%
Revenue growth 3Y-7.71%
Revenue growth 5Y14.06%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-78.66%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-59.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMCM Yearly Revenue VS EstimatesCMCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2026 1B 2B 3B 4B 5B
CMCM Yearly EPS VS EstimatesCMCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2026 0 10 20 30 40

4

4. Valuation

4.1 Price/Earnings Ratio

CMCM is valuated cheaply with a Price/Earnings ratio of 3.51.
CMCM's Price/Earnings ratio is rather cheap when compared to the industry. CMCM is cheaper than 97.83% of the companies in the same industry.
CMCM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 16.43, the valuation of CMCM can be described as correct.
CMCM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CMCM is cheaper than 86.59% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CMCM to the average of the S&P500 Index (22.68), we can say CMCM is valued slightly cheaper.
Industry RankSector Rank
PE 3.51
Fwd PE 16.43
CMCM Price Earnings VS Forward Price EarningsCMCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMCM Per share dataCMCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CMCM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHEETAH MOBILE INC - ADR

NYSE:CMCM (2/21/2025, 8:10:08 PM)

After market: 6.08 +0.33 (+5.74%)

5.75

-0.17 (-2.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-22 2024-11-22
Earnings (Next)03-17 2025-03-17
Inst Owners1.47%
Inst Owner Change12.67%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap171.83M
Analysts36.67
Price TargetN/A
Short Float %0.02%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.51
Fwd PE 16.43
P/S 1.86
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)1.64
EY28.52%
EPS(NY)0.35
Fwd EY6.09%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.09
BVpS11.33
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.7%
ROE -24.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.36%
FCFM N/A
ROA(3y)-9.32%
ROA(5y)-5.13%
ROE(3y)-17.51%
ROE(5y)-9.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.97%
GM growth 5Y-1.1%
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 0.24
F-ScoreN/A
WACC12.47%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.77%
EPS 3Y14.63%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-78.66%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.98%
Revenue growth 3Y-7.71%
Revenue growth 5Y14.06%
Sales Q2Q%N/A
Revenue Next Year-59.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A